Nanobiotix signs deal with Janssen for cancer drug NBTXR3
PARIS, FRANCE: Nanobiotix, a biotechnology company developing nanotherapeutics for cancer, has announced a global deal with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies...
Nanobiotix announces key development milestones for 2021 after successful Nasdaq IPO
PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix is a clinical-stage biotechnology company focused on developing first-in-class product candidates that use...